MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Assessing Executive Function in HD: Comparing the One Touch Stockings of Cambridge and Zindametrix’s Tower-Z as Components of the HD-CAB

    M. Roche, G. Phelan, N. Sinha, A. Patel, A. Mansbach, H. Wilkinson, R. Fuller, J. Stout, S. Lazic, I. Antonijevic, S. Sathe, C. Sampaio (Princeton, USA)

    Objective: To assess the comparability of performance by people with Huntington’s disease (HD) on two tower tasks. Background: Cognitive decline is a hallmark feature of…
  • 2024 International Congress

    Medication Refractory Restless Legs Syndrome: Real-World Experience

    P. Petramfar, J. Jankovic (Houston, USA)

    Objective: To identify demographic or clinical factors predictive of refractory cases. Background: Restless Legs Syndrome (RLS), impacting 5-13% of the US population, poses challenges in…
  • 2024 International Congress

    Pathways for diagnosis and multimodal management, including botulinum neurotoxin therapy, in shoulder conditions following central lesions

    B. Biering-Sørensen, C. Cordero-García, C. Boulias, D. Hoad, D. Bensmail, F. Molteni, F. Genêt, J. Wissel, P. Marque, S. Berweck, J. Jacinto (Glostrup, Denmark)

    Objective: To build on existing publications and give guidance for healthcare providers managing shoulder conditions following central lesions, including how to identify, diagnose, and treat…
  • 2024 International Congress

    Suvecaltamide Metabolites Are CaV3 Modulators and Contribute to Pharmacological Effect

    E. Brigham, W. Zeng, N. Shanks, M. Lee (Palo Alto, USA)

    Objective: To determine the potency-concentration relationships and combined pharmacological effects for suvecaltamide and its 2 active metabolites (JZZ05000034=M01, JZZ05000035=M02; total active moiety [TAM]). Background: T-type…
  • 2024 International Congress

    Cortical response to proprioceptive stimulation in orthostatic tremor – a magnetoencephalography study

    K. Af Edholm, M. Vinding, C. Pfeiffer, D. Lundqvist, J. Waldthaler (Danderyd, Sweden)

    Objective: To investigate cortical integration of proprioceptive information in patients with orthostatic tremor (OT), measured as event-related synchronisation (ERS) response to proprioceptive stimulation using magnetencephalography…
  • 2024 International Congress

    Secondary orthostatic tremor associated with hyperthyroidism: A case report

    T. Dang, K. Vo, T. Tran (HO CHI MINH, Viet Nam)

    Objective: To illustrate the electrophysiological and clinical findings in a patient with secondary orthostatic tremor (OT) associated with hyperthyroidism Background: Orthostatic tremor is a rare…
  • 2024 International Congress

    Movement Disorders Associated with Infectious Encephalitis in Pediatric Patients

    M. Mnif, H. Benrhouma, T. Benyounes, H. Klaa, Z. Miladi, A. Zioudi, I. Turki, I. Kraoua (Tunis, Tunisia)

    Objective: The objective of our study is to report the clinical and imaging profile of a cohort of pediatric patients with movement disorders (MDs) associated…
  • 2024 International Congress

    Expanding the phenotypic spectrum of movement disorders in 22q11.2 deletion syndrome

    N. Reyes, T. Cortez-Grippe, M. Callister, T. Heung, A. Bassett, A. Lang (Toronto, Canada)

    Objective: To formally characterize the evolving spectrum of movement disorders associated with chromosome 22q11.2 deletion syndrome Background: Emerging evidence suggests that a wide range of…
  • 2024 International Congress

    The functional consequences of the ‘African GBA1 allele’ of rs3115534 in Parkinson’s Disease

    M. Radefeldt, L. Demuth, R. Al-Ali, S. Fischer, C. Beetz, P. Bauer (Rostock, Germany)

    Objective: To gain insights into the pathophysiology by which the G-allele of rs3115534 confers risk for PD. Background: A recent paper defined the G-allele of…
  • 2024 International Congress

    RAB32 c.213C>G (p.Ser71Arg) explains Parkinson’s disease in two UK families: description of the clinical and biochemical features

    R. Tilney, R. Real, E. Gustavsson, S. Jasaityte, Y. Kordovska, M. Fenn, P. Korlipara, M. Hu, E. Sammler, M. Farrer, H. Morris (London, United Kingdom)

    Objective: To describe the clinical features, family structure of two families identified to have the recently described pathogenic variant RAB32 c.213C>G (p.Ser71Arg). Background: Genetic mutations…
  • « Previous Page
  • 1
  • …
  • 135
  • 136
  • 137
  • 138
  • 139
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley